31.03.2026 – 3min

Maternal Immune Activation as a Neurodevelopmental Risk Factor: New Insights into ADHD-Like Endophenotypes in a Mouse Model

Overview

Epidemiological evidence consistently links maternal infection during pregnancy to elevated offspring risk for neurodevelopmental disorders, including ADHD, schizophrenia, and autism spectrum disorder. Yet the mechanistic pathways connecting prenatal immune challenge to specific behavioral and neurochemical outcomes remain incompletely understood.

A new study from Prof. Dr. Urs Meyer and colleagues at the University of Zurich addresses this gap, integrating longitudinal behavioral phenotyping, neurochemical profiling, and pharmacological validation into a cohesive translational framework.

Who Gets Affected and Why Does It Matter?

Not all MIA-exposed animals develop the same phenotype. 40–50% of male offspring showed locomotor hyperactivity during adolescence, progressing in adulthood to impulsivity and prepulse inhibition (PPI) deficits – hallmarks of impaired sensorimotor gating. The remaining animals were behaviorally indistinguishable from controls.

This susceptible/resilient stratification mirrors the heterogeneous penetrance of human neurodevelopmental conditions and creates a methodologically powerful framework: researchers can directly compare neurobiological profiles between subgroups and design better-powered pharmacological studies, rather than averaging across an entire cohort.

IntelliCage: Automated Home-Cage Phenotyping for Longitudinal ADHD Research

To characterize impulsivity and reward-related behavior with the resolution these constructs demand, the Meyer lab employed the IntelliCage system — a fully automated, home-cage behavioral phenotyping platform for group-housed mice. Unlike episodic, handling-dependent paradigms such as the open field or elevated plus maze, IntelliCage enables continuous, within-subject monitoring across weeks or months without experimenter interference.

Key behavioral constructs assessed using IntelliCage:

• Reward preference and incentive motivation — probing hedonic processing and effort-based decision-making relevant to ADHD reward circuitry
• Delay-of-reinforcement impulsivity — a translationally validated construct mapping directly onto clinical impulsivity measures in human ADHD

The longitudinal, bias-free dataset generated by IntelliCage provided temporal resolution and within-subject sensitivity unavailable through conventional discrete-trial approaches — making it particularly well suited to neurodevelopmental models where behavioral phenotypes emerge and evolve gradually.

Neurochemical Correlates and Pharmacological Validation

Susceptible animals showed age-dependent alterations in dopamine (DA) and norepinephrine (NE) signaling across prefrontal and striatal circuits – the same systems dysregulated in human ADHD. These neurochemical shifts correlated directly with behavioral stratification, anchoring the endophenotypes in circuit-level biology and evolving in parallel with the temporal emergence of behavioral symptoms.

Methylphenidate (MPH), a DA/NE reuptake inhibitor and first-line ADHD pharmacotherapy, normalized hyperactivity and reversed abnormal neuronal activation patterns, but only in susceptible animals. This selectivity confirms that the susceptible subpopulation is biologically distinct and pharmacologically responsive, satisfying criteria for face, construct, and predictive validity.

Key Takeaways for Mouse Model Researchers

This study makes a compelling case for moving beyond group-level MIA vs. control comparisons. Three principles stand out:

• Intra-cohort stratification reveals biological signal that aggregate analyses would obscure
• Automated longitudinal platforms provide the temporal resolution needed for evolving constructs like impulsivity
• Pharmacological benchmarking against a clinical reference is essential before deploying a model for novel compound screening

We are proud that IntelliCage contributed to the methodological backbone of this work. The full study is available for those wishing to explore the experimental design and dataset in detail: Maternal immune activation in mice recapitulates features of attention-deficit/hyperactivity disord…

Discover more about InterlliCage in our Newest Brochure.

More Scientific Insights

Comparison diagram: classical single-session cognitive testing in isolated novel apparatus versus longitudinal home-cage testing in group-housed mice Funnel diagram showing over 400 Alzheimer's drug compounds tested in mice narrowing to fewer than 5 with human clinical efficacy

Why Alzheimer's Mouse Models Show Cognitive Rescue That Doesn't Translate

Over 400 drugs have rescued cognition in Alzheimer’s mouse models. Fewer than 5 have shown efficacy in humans (Langness et al., 2025). That gap is...

Learn more

IntelliCage automated home-cage behavioral testing system with group-housed mice and RFID-equipped operant conditioning corners

8 Drug Classes Tested in IntelliCage: What Group-housed Cognitive Phenotyping Revealed that Standard Tests Missed

IntelliCage is an automated home-cage behavioral testing system developed by TSE Systems. It enables continuous cognitive phenotyping of group-housed rodents using RFID individual identification and...

Learn more

LinkedIn post by TSE Systems about behavioral phenotyping. Image shows gloved hands holding a pipette over a sample in a laboratory setting. Text reads: 'The Best Data Comes From Animals That Don't Know They're Being Tested' with subtitle 'A principle for behavioral phenotyping that changes what you measure.' Cyan 'Best Practices' badge in top right corner

How Handling Stress Contaminates Behavioral Data and What to do Instead

There is a confounder in almost every behavioral neuroscience study that nobody mentioned in the methods section. Handling stress. The moment you pick up an...

Learn more

**Alt text:** Schematic summary of a 2026 Molecular Cell study from Prof. Christian Wolfrum’s lab describing MEDAG as a molecular regulator of adipocyte metabolism. The figure illustrates MEDAG (mesenteric estrogen-dependent adipogenesis gene) acting as an A-kinase anchoring protein (AKAP) that binds the regulatory subunit PKA-RIIβ to organize protein kinase A (PKA) signaling complexes in fat cells. A feedback loop is shown in which activated PKA phosphorylates MEDAG, and phosphorylated MEDAG helps restrain further PKA activity, limiting signaling intensity. In adipocyte-specific Medag knockout mice, loss of this restraint leads to increased PKA activity, higher energy expenditure, protection from diet-induced obesity, and a shift toward increased carbohydrate utilization without changes in food intake or physical activity. Whole-body metabolic changes were measured using indirect calorimetry in the PhenoMaster system from TSE Systems, confirming increased energy dissipation in adipose tissue.

A Newly Discovered Molecular Brake on Fat Metabolism: The Role of MEDAG

A recent study from Prof. Christian Wolfrum’s lab, published in Molecular Cell (2026), provides compelling new insights into how adipose tissue regulates energy balance. At...

Learn more